{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(Suppl 1)"],"submitter":["Terrault N"],"journal":["Clinical liver disease"],"pagination":["S1-S5"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6490216"],"repository":["biostudies-literature"],"pubmed_title":["Estrategias para el tratamiento de pacientes con infeccion por el virus de la hepatitis B sometidos a terapia inmunomoduladora: ¿es suficiente usar lamivudina?"],"pmcid":["PMC6490216"],"pubmed_authors":["Terrault N"],"additional_accession":[]},"is_claimable":false,"name":"Estrategias para el tratamiento de pacientes con infeccion por el virus de la hepatitis B sometidos a terapia inmunomoduladora: ¿es suficiente usar lamivudina?","description":null,"dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Nov","modification":"2025-04-05T13:10:26.247Z","creation":"2025-04-05T13:10:26.247Z"},"accession":"S-EPMC6490216","cross_references":{"pubmed":["31041087"],"doi":["10.1002/cld.595"]}}